COMP <GO>
ORCL vs NVDA // ALTMAN Z-SCORE & DEBT/EQUITY
Oracle Corporation (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: ORCL 5
— NVDA 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: NVDA
LAST: $130.67 (-6.37%) • MKT CAP: $405.97B
balance-sheet
1.54
LAST: $204.64 (-4.22%) • MKT CAP: $4.98T
balance-sheet
19.52
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORCL VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ORCL | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.67% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.39% | 65.06% | -53.67 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.9x | 23.4x | -5.50 | ORCL | /valuation <GO> |
| Free Cash Flow Yield | -7.07% | 2.55% | -9.62 | NVDA | /fcf-yield <GO> |
| Operating Margin | 32.12% | 65.21% | -33.09 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 26.36% | 63.66% | -37.30 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 21.62% | 83.38% | -61.76 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.53% | 0.02% | +1.51 | ORCL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.54 | 19.52 | -17.98 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | ORCL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 11.57% | 9.01% | +2.56 | NVDA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.6 | 35.1 | +10.56 | ORCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 2.04 | -0.67 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.5x | 17.0x | -0.48 | ORCL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $405.97B | $4.98T | -$4.57T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ORCL REV | NVDA REV | ORCL GROSS % | NVDA GROSS % | ORCL FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | $67.36B | $215.94B | — | 71.1% | -$23.69B | $96.68B |
| FY 2025 | $57.40B | $130.50B | — | 75.0% | -$394.0M | $60.85B |
| FY 2024 | $52.96B | $60.92B | — | 72.7% | $11.81B | $27.02B |
| FY 2023 | $49.95B | $26.97B | — | 56.9% | $8.47B | $3.81B |
| FY 2022 | $42.44B | $26.91B | — | 64.9% | $5.03B | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORCL // BETA 1.37
NVDA // BETA 2.04